Lab Manager
The therapeutic protein market shows no signs of slowing down, with thousands of recruiting and active clinical trials underway in the United States. Scientific Advisor Andrew Hanneman, Ph.D. discusses the safety and consistency of profiling glycans with Lab Manager Magazine.